SMTL ID : 4cbr.1

X-ray structure of the more stable human AGXT triple mutant (AGXT_HEM)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

homo-dimer

Ligands

2 x PLP: PYRIDOXAL-5'-PHOSPHATE(Covalent)

PLP.1: 15 residues within 4Å: Chain A: S.81, G.82, H.83, W.108, G.156, S.158, D.183, V.185, A.186, Q.208, K.209 Chain B: Y.260, H.262, T.263 Ligands: GOL.2 15 PLIP interactions: 11 interactions with chain A, 4 interactions with chain B Hydrophobic interactions: A:W.108, A:V.185, A:K.209 Hydrogen bonds: A:G.82, A:H.83, A:S.158, A:S.158, A:Q.208, B:Y.260, B:Y.260, B:T.263, B:T.263 Salt bridges: A:H.83, A:K.209 pi-Stacking: A:W.108 PLP.3: 15 residues within 4Å: Chain A: Y.260, H.262, T.263 Chain B: S.81, G.82, H.83, W.108, G.156, S.158, D.183, V.185, A.186, Q.208, K.209 Ligands: GOL.4 13 PLIP interactions: 2 interactions with chain A, 11 interactions with chain B Hydrogen bonds: A:Y.260, A:T.263, B:G.82, B:H.83, B:S.158, B:S.158, B:Q.208 Hydrophobic interactions: B:W.108, B:V.185, B:K.209 Salt bridges: B:H.83, B:K.209 pi-Stacking: B:W.108

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 8 residues within 4Å: Chain A: P.28, G.29, K.209, L.351, R.360 Chain B: H.48, Y.260 Ligands: PLP.1 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:K.209, A:R.360, A:R.360 Water bridges: A:K.209 GOL.4: 8 residues within 4Å: Chain A: H.48, Y.260 Chain B: P.28, G.29, K.209, L.351, R.360 Ligands: PLP.3 4 PLIP interactions: 1 interactions with chain A, 3 interactions with chain B Water bridges: A:T.263 Hydrogen bonds: B:K.209, B:R.360, B:R.360

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mesa-Torres, N. et al., The Consensus-Based Approach for Gene/Enzyme Replacement Therapies and Crystallization Strategies: The Case of Human Alanine:Glyoxylate Aminotransferase. Biochem.J. (2014)

Release Date

2014-07-09

Peptides

SERINE--PYRUVATE AMINOTRANSFERASE: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

SERINE--PYRUVATE AMINOTRANSFERASE